Can anti –PGL-1 and anti–NDO-LID-1 antibody titers be used to predict the risk of reactions in leprosy patients?

This study aimed at evaluating anti –Mycobacterium leprae antibody levels in reactional and nonreactional leprosy patients at the time of diagnosis. Clinical data and serum samples of 224 patients diagnosed between 2009 and 2010 were collected in the municipality of Rondonópolis-MTBR. Quantification of anti–phenolic glycolipid-1 (PGL-1) IgM antibodies of M.

Source: Diagnostic Microbiology and Infectious Disease - March 15, 2018 Category: Microbiology Authors: Amanda Carreira Devides, Patricia Sammarco Rosa, Andr éa de Faria Fernandes Belone, Neusa Maria Broch Coelho, Somei Ura, Eliane Aparecida Silva Source Type: research